| __timestamp | PTC Therapeutics, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 44820000 | 504755000 |
| Thursday, January 1, 2015 | 82080000 | 838526000 |
| Friday, January 1, 2016 | 97130000 | 1177697000 |
| Sunday, January 1, 2017 | 121271000 | 1320433000 |
| Monday, January 1, 2018 | 153548000 | 1556200000 |
| Tuesday, January 1, 2019 | 202541000 | 1834800000 |
| Wednesday, January 1, 2020 | 245164000 | 1346000000 |
| Friday, January 1, 2021 | 285773000 | 1824900000 |
| Saturday, January 1, 2022 | 325998000 | 2115900000 |
| Sunday, January 1, 2023 | 332540000 | 2631300000 |
| Monday, January 1, 2024 | 2954400000 |
Unlocking the unknown
In the competitive world of biotechnology, managing expenses is crucial for sustained growth. Over the past decade, Regeneron Pharmaceuticals, Inc. and PTC Therapeutics, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Regeneron's SG&A expenses surged by over 400%, peaking in 2023. This reflects their aggressive expansion and investment in marketing and administrative capabilities. In contrast, PTC Therapeutics experienced a more modest increase of approximately 640% during the same period, indicating a steady yet cautious approach to scaling operations. Notably, Regeneron's expenses consistently outpaced PTC's, highlighting their larger market footprint. These trends underscore the strategic financial decisions each company has made in response to market demands and growth opportunities. As the biotech industry continues to evolve, monitoring these financial metrics will be key to understanding future trajectories.
Comparing SG&A Expenses: AstraZeneca PLC vs Regeneron Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Summit Therapeutics Inc.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Intra-Cellular Therapies, Inc. Trends and Insights
Regeneron Pharmaceuticals, Inc. vs Axsome Therapeutics, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs ImmunityBio, Inc.
Regeneron Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Insmed Incorporated vs PTC Therapeutics, Inc.
Alkermes plc or PTC Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: CymaBay Therapeutics, Inc. vs PTC Therapeutics, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Who Optimizes SG&A Costs Better? PTC Therapeutics, Inc. or Celldex Therapeutics, Inc.